Alphatec Hlds

Alphatec Holdings, Inc. engages in the design, development, and marketing of spinal fusion technology products and solutions for the treatment of spinal disorders. It offers intra-operative information and neuromonitoring technologies, access systems, interbody implants, fixation systems, and various biologics offerings. The company was founded on March 4, 2005 and is headquartered in Carlsbad, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Alphatec (ATEC) posts robust earnings, eyes growth through innovation

Alphatec (ATEC) delivered strong financial results in Q4 2022, with revenue growth, operational improvements, and a positive outlook for 2023.
The company's focus on innovation, surgeon adoption, and profitability underscores its strategic approach to sustainable growth and market leadership.
ATEC faces challenges in margin improvement, achieving EBITDA targets, and navigating competitive consolidation in the spine space.
However, the company remains optimistic, leveraging opportunities in procedural expansion, technological innovation, and international market expansion for future success.

Alphatec (ATEC) reports stellar Q1 growth and strategic acquisitions

Alphatec (ATEC) showcased robust revenue growth, strategic acquisitions, and a focus on enhancing procedural efficiency and surgeon adoption.
While challenges exist in achieving EBITDA break-even and expanding margins, ATEC's strong performance and growth outlook present promising opportunities.
The company's emphasis on technology integration, international expansion, and increasing robotics utilization positions ATEC for future success.

Alphatec (ATEC) reports robust Q2 growth and eyes international expansion

Alphatec's Q2 performance reflects strong revenue growth, margin expansion, and market share gains driven by strategic initiatives in spine surgery. The company's focus on innovation, surgeon adoption, and geographic expansion positions it well for future growth and success in the spine market.

Alphatec (ATEC) reports robust Q3 earnings, eyes growth opportunities

Alphatec (ATEC) delivered strong financial performance in Q3 2023, driven by revenue growth, positive adjusted EBITDA, and strategic initiatives.
The company's strengths lie in its spine surgery focus, new product launches, and advancements in informatics and robotic integration.
Challenges include managing risks, balancing growth with profitability, and navigating market disruptions, while opportunities exist in expansion and technology integration.

Alphatec (ATEC) reports robust Q4 performance, eyes international expansion

Alphatec (ATEC) had a strong Q4 2023, focusing on clinical excellence and market share growth. Challenges include managing debt and sustaining momentum. Opportunities lie in international expansion and innovative product launches.

Alphatec Hlds (ATEC) reports robust Q1 performance and growth outlook

Alphatec Hlds (ATEC) delivered a strong Q1 2024 performance with significant revenue growth, surgeon adoption, and sales team confidence, underpinned by a focus on innovation and market expansion.
While facing challenges in debt management and profitability, the company's strategic outlook, financial strength, and growth drivers position it well for future success and sustained growth.
By capitalizing on opportunities in technology integration, international expansion, and market share expansion, Alphatec is poised to drive continued innovation and value creation in the spine surgery market.

Alphatec Hlds (ATEC) reports robust Q2 growth and eyes Japan expansion

Alphatec Hlds (ATEC) delivered strong financial results in Q2 2024, showcasing growth in revenue, profitability, and surgeon engagement, while focusing on innovation and clinical distinction.
The company faces challenges in achieving cash flow break-even, entering new markets like Japan, and expanding into deformity surgery, but sees opportunities in market growth and technological advancements.
Overall, Alphatec Hlds (ATEC) remains committed to advancing spine surgery through technology, attracting surgeons to advanced tools, and driving sustainable growth through strategic initiatives.

Alphatec (ATEC) excels in Q3 earnings, eyes growth opportunities

Alphatec (ATEC) reported a robust Q3 performance marked by strong revenue growth and positive adjusted EBITDA, driven by surgical and EOS revenue increases. While challenges in gross margin and cash flow breakeven exist, the company remains optimistic about long-term financial commitments and revenue growth. ATEC's strategic focus on value creation, surgeon adoption, and innovation positions it well for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CARLSBAD, Calif.--(BUSINESS WIRE)-- #ATEC--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2021 financial results on November 4, 2021, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast Participants To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Websit

ATEC to Report Third Quarter Financial Results on November 4, 2021

CARLSBAD, Calif.--(BUSINESS WIRE)-- #ATEC--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today the launch of the InVictus OsseoScrew Expandable Spinal Fixation System. InVictus OsseoScrew has been designed to be an alternative to the conventional use of cemented fenestrated screws for patients with compromised bone. The system is intended to restore spinal column integrity, even in the absence of fusion,

ATEC Expands Platform with Launch of InVictus® OsseoScrew® Expandable Spinal Fixation

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, provided a business update today, ahead of investor meetings scheduled for the NASS 2021 meeting. The resurgence of COVID-19 in the U.S. has pressured surgical procedure volumes in spine and affected hospital operations in the third quarter of 2021, with the impact persisting into the final month of the period. While procedure

ATEC Provides Business Update

CARLSBAD, Calif.--(BUSINESS WIRE)-- #ATEC--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that the Company's comprehensive procedural portfolio will be featured at the North American Spine Society (NASS) Annual Meeting, which will be held at the Boston Convention and Exhibition Center from September 29 through October 1, 2021. “We are excited to feature the breadth of clinically distinct products and

ATEC to Feature Comprehensive Procedural Solutions at NASS 2021

Business momentum continues to accelerate as evidenced by the recent blow-out second quarter results and related guidance raise.

Alphatec Holdings: Buy With Both Hands As Business Momentum Continues To Build

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) today announced the pricing of its offering of $275,000,000 aggregate principal amount of 0.75% convertible senior notes due 2026 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from the previously announced offering size of $250,000,000 aggregate principal amount of notes. The i

Alphatec Holdings, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) today announced its intention to offer, subject to market and other conditions, $250,000,000 aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Alphatec also expects to grant the initial purchasers of the notes an option to purchase, for settlement wi

Alphatec Holdings, Inc. Announces Proposed Convertible Senior Notes Offering

Alphatec Holdings, Inc. (ATEC) CEO Patrick Miles on Q2 2021 Results - Earnings Call Transcript

CARLSBAD, Calif.--(BUSINESS WIRE)-- #alphatec--ATEC reports Q2 2021 Financial Results

ATEC Reports Second Quarter Financial Results and Recent Corporate Highlights

Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Alphatec (ATEC) Q2 Earnings Expected to Decline

CARLSBAD, Calif., July 26, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Beth Altman, former Managing Partner at KPMG LLP San Diego, has been appointed as an independent director to the ATEC Board of Directors ("Board") and as Chair of the Audit Committee of the Board, with both appointments to be effective as of August 12, 2021. The Company also announced the resignation of Donald A. Williams as an independent director and as Chair of the Audit Committee of the Board and member of its Finance Committee, with such resignations effective as of August 11, 2021.

ATEC Appoints Beth Altman to Board of Directors

After a troubled past, Alphatec has seen huge sales traction over the past two years. Rapid growth in a Covid-19-impacted market shows real strength, albeit that losses have not come down yet.

Alphatec - Strong Momentum, Still Concerns

Second quarter 2021 U.S. organic revenue expected to range from $55.4 million to $56.0 million

ATEC Announces Select Preliminary Second Quarter 2021 Financial Results

CARLSBAD, Calif., June 21, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., founder of EOS imaging, has been appointed as an independent director to the ATEC Board.

ATEC Appoints Marie Meynadier, Ph.D., to Board of Directors

Union Will Better Inform Spine Surgery Union Will Better Inform Spine Surgery

ATEC Welcomes EOS Imaging Team

PARIS--(BUSINESS WIRE)--Strong Success of the Tender Offer Initiated by Alphatec Holdings for Common Shares and Oceanes of EOS imaging

Strong Success of the Tender Offer Initiated by Alphatec Holdings for Common Shares and Oceanes of EOS imaging

CARLSBAD, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chairman and Chief Executive Officer, will present at the Canaccord Genuity Virtual Musculoskeletal Conference on May 20, 2021, at 1:30 pm EDT. ATEC management will also participate in meetings with registered conference attendees.

ATEC to Virtually Participate in the Canaccord Genuity Musculoskeletal Conference

Alphatec Holdings' (ATEC) CEO Pat Miles on Q1 2021 Results - Earnings Call Transcript

CARLSBAD, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended March 31, 2021, and recent corporate highlights.

ATEC Reports First Quarter Financial Results and Recent Corporate Highlights

Avid Bioservices

Organogenesis Holdings

Healthcare has been lagging the market, but that is now changing. As biotechs consolidate, other healthcare industry groups are powering the sector to a breakout.

3 Healthcare Stocks As The Sector Breaks Out To New Highs

CARLSBAD, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2021 financial results on May 6, 2021, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET.

ATEC to Report First Quarter Financial Results on May 6, 2021

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Alphatec (ATEC) Surges 11.4%: Is This an Indication of Further Gains?

First quarter 2021 U.S. revenue grows approximately 50% compared to last year

ATEC Announces Preliminary First Quarter 2021 Revenue Results and Provides Corporate Updates

CARLSBAD, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that Pat Miles, Chairman and Chief Executive Officer, will virtually present at the 20th Annual Needham Healthcare Conference on April 13, 2021, at 10:30 am PT. ATEC management will also participate in meetings with registered conference attendees.

ATEC to Virtually Participate in the 20th Annual Needham Healthcare Conference

Addus HomeCare

Amyris

Amazon

Microsoft

TipRanks analyst ranking service pinpoints Wall Street's best-performing stocks, like Amazon and Microsoft

News for Alphatec Hlds Stock (ATEC)